| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 35 |
| 1 | MYCOPHENOLATE MOFETIL | 31 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 31 |
| 3 | HYDROXYCHLOROQUINE SULFATE | 30 |
| 4 | METHOTREXATE SODIUM | 30 |
| 5 | AZATHIOPRINE | 29 |
| 6 | ETANERCEPT | 29 |
| 7 | METHOTREXATE | 29 |
| 8 | INFLIXIMAB | 28 |
| 9 | ACETAMINOPHEN | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 1 | 0.0070 |
| 1 | HYDRALAZINE HYDROCHLORIDE | 3 | 0.0011 |
| 2 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 3 | ANIFROLUMAB-FNIA | 2 | 0.0010 |
| 4 | METRELEPTIN | 1 | 0.0008 |
| 5 | BELIMUMAB | 12 | 0.0004 |
| 6 | HYDROXYCHLOROQUINE SULFATE | 30 | 0.0003 |
| 7 | AZATHIOPRINE | 29 | 0.0003 |
| 8 | VITAMIN C | 24 | 0.0003 |
| 9 | MYCOPHENOLATE MOFETIL | 31 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 42 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 36 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 29 |
| 3 | Purine Antimetabolite [EPC] | 29 |
| 4 | Vitamin C [EPC] | 29 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 6 | Expectorant [EPC] | 20 |
| 7 | Alkylating Drug [EPC] | 17 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 12 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Type I Interferon Receptor Antagonist [EPC] | 2 | 0.0010 |
| 1 | Leptin Analog [EPC] | 1 | 0.0008 |
| 2 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 12 | 0.0004 |
| 3 | Purine Antimetabolite [EPC] | 29 | 0.0003 |
| 4 | Expectorant [EPC] | 20 | 0.0001 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 6 | Sulfone [EPC] | 1 | 0.0001 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 11 | 0.0001 |
| 8 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 9 | Alkylating Drug [EPC] | 17 | 0.0001 |